Skip to content

Effect of Ischemic Preconditioning on Atrial Fibrillation After Electrocardioversion

Effect of Ischemic Preconditioning on Relapse of Nonvalvular Atrial Fibrillation After Electrocardioversion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05342220
Acronym
PRECON-AF
Enrollment
240
Registered
2022-04-22
Start date
2022-04-01
Completion date
2024-06-30
Last updated
2024-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Remote ischemic preconditioning is one way to influence the success of therapy in cardiovascular patients. By means of remote ischemic preconditioning the incidence of atrial fibrillation after cardiac surgery was reduced by 54%. The investigators aim to investigate the effect of ischemic preconditioning in an easy-to-perform protocol with regard to the recurrence of atrial fibrillation after electrical cardioversion.

Interventions

PROCEDURERemote ischemic preconditioning

Remote ischemic preconditioning through inflation of a blood pressure cuff to pressure values \> 200mmHg for 5 minutes followed by 5 minutes of reperfusion (3 times each) before electrocardioversion Electrical cardioversion for atrial fibrillation (100, 150, 200 Joule)

Inflation of a blood pressure cuff to pressure values \ 10mmHg for 5 minutes followed by 5 minutes of reperfusion (3 times each) before electrocardioversion

Sponsors

St. Josefs-Hospital Wiesbaden GmbH
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients with paroxysmal or persistent atrial fibrillation who give written informed consent to participate in the study * Age \> 18 years * Consent capacity

Exclusion criteria

* Age under 18 years * Pregnancy * Lack of consent capacity

Design outcomes

Primary

MeasureTime frame
Number of subjects with recurrence of atrial fibrillation 30 days after electrical cardioversion30 days

Secondary

MeasureTime frameDescription
Number of patients with short-term cardioversion success30 secondsSinus rhythm lasting \> 30 seconds after electrocardioversion
Minimum energy required for successful electrocardioversion (in Joule)30 days
Cumulative energy applied for successfull electrocardioversion (in Joule)30 days
Cumulative number of shocks delivered for successfull electrocardioversion30 days
Number of patients experiencing death from any cause, stroke /transient ischemic attack, relevant post-ECV arrhythmia and procedure-associated complications30 daysSafety endpoint

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026